Novo Nordisk is making waves in the obesity treatment landscape by introducing its Wegovy pill at a competitive price point, directly challenging Eli Lilly’s offerings. This strategic pricing aims to attract consumers who prefer to pay out-of-pocket for healthcare solutions, particularly amid the ri
Novo Nordisk’s Strategic Move in the Obesity Treatment Market


















































































































































































































































































































































































































































































































































































































